Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis Open new browser tab
(2023)
Start website main content
(2023)
(2023)
(2023)
(2023)
(2023)
(2023)
(2023)
(2023)
(2023)
(2023)